[1] |
SCHÄCKE G, SCUTARU C, GRONEBERG D A. Effect of aircraft-cabin altitude on passenger discomfort[J]. N Engl J Med, 2007, 357(14):1445-1446. DOI: 10.1056/nejmc072206.
|
[2] |
IMRAY C, WRIGHT A, SUBUDHI A, et al. Acute Mountain sickness:pathophysiology,prevention,and treatment[J]. Prog Cardiovasc Dis, 2010, 52(6):467-484. DOI: 10.1016/j.pcad.2010.02.003.
|
[3] |
BÄRTSCH P, SALTIN B. General introduction to altitude adaptation and mountain sickness[J]. Scand J Med Sci Sports, 2008, 18(Suppl 1):1-10. DOI: 10.1111/j.1600-0838.2008.00827.x.
|
[4] |
MEIER D, COLLET T H, LOCATELLI I, et al. Does this patient have acute mountain sickness? :the rational clinical examination systematic review[J]. JAMA, 2017, 318(18):1810-1819. DOI: 10.1001/jama.2017.16192.
|
[5] |
|
[6] |
GRISSOM C K, ROACH R C, SARNQUIST F H, et al. Acetazolamide in the treatment of acute mountain sickness:clinical efficacy and effect on gas exchange[J]. Ann Intern Med,1992,116(6):461-465.
|
[7] |
KELLER H R, MAGGIORINI M, BÄRTSCH P, et al. Simulated descent v dexamethasone in treatment of acute mountain sickness:a randomised trial[J]. BMJ Clin Res Ed,1995,310(6989):1232-1235.
|
[8] |
BASNYAT B, GERTSCH J H, HOLCK P C. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness[J]. High Alt Med Biol, 2008, 9(4):349;authorreply351-349;authorreply352. DOI: 10.1089/ham.2008.1060.
|
[9] |
SCHOMMER K, WIESEGATR N, MENOLD E, et al. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m [J]. High Alt Med Biol, 2010, 11(1):19-25. DOI: 10.1089/ham.2009.1019.
|
[10] |
FULCO C S, BEIDLEMAN B A, MUZA S R. Effectiveness of preacclimatization strategies for high-altitude exposure [J]. Exerc Sport Sci Rev, 2013, 41(1):55-63. DOI: 10.1097/JES.0b013e31825eaa33.
|
[11] |
NAVARRETE-OPAZO A, MITCHELL G S. Therapeutic potential of intermittent hypoxia:a matter of dose[J]. Am J Physiol Regul Integr Comp Physiol, 2014, 307(10):R1181-1197. DOI: 10.1152/ajpregu.00208.2014.
|
[12] |
BROCHERIE F, MILLET G P. Hypoxic exercise as an effective nonpharmacological therapeutic intervention [J]. Exp Mol Med, 2020, 52(3):529-530. DOI: 10.1038/s12276-020-0400-6.
|
[13] |
ROACH R C, HACKETT P H, OELZ O, et al. The 2018 lake louise acute mountain sickness score[J]. High Alt Med Biol, 2018, 19(1):4-6. DOI: 10.1089/ham.2017.0164.
|
[14] |
BURTSCHER M, WILLE M, MENZ V, et al. Symptom progression in acute mountain sickness during a 12-hour exposure to normobaric hypoxia equivalent to 4500 m [J]. High Alt Med Biol, 2014, 15(4):446-451. DOI: 10.1089/ham.2014.1039.
|
[15] |
HUNYOR I, COOK K M. Models of intermittent hypoxia and obstructive sleep apnea:molecular pathways and their contribution to cancer[J]. Am J Physiol Regul Integr Comp Physiol, 2018, 315(4):R669-687. DOI: 10.1152/ajpregu.00036.2018.
|
[16] |
LIU J, GU Y K, GUO M Y, et al. Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases[J]. CNS Neurosci Ther, 2021, 27(8):869-882. DOI: 10.1111/cns.13642.
|
[17] |
RYBNIKOVA ELENA A, NALIVAEVA NATALIA N, ZENKO MIKHAIL Y, et al. Intermittent hypoxic training as an effective tool for increasing the adaptive potential,endurance and working capacity of the brain [J]. Front Neurosci, 2022, 16:941740. DOI: 10.3389/fnins.2022.941740.
|
[18] |
HAMLIN M J, LIZAMORE C A, HOPKINS W G. The effect of natural or simulated altitude training on high-intensity intermittent running performance in team-sport athletes:a meta-analysis[J]. Sports Med, 2018, 48(2):431-446. DOI: 10.1007/s40279-017-0809-9.
|
[19] |
WILLE M, GATTERER H, MAIRER K, et al. Short-term intermittent hypoxia reduces the severity of acute mountain sickness [J]. Scand J Med Sci Sports, 2012, 22(5):e79-85. DOI: 10.1111/j.1600-0838.2012.01499.x.
|
[20] |
ANAMIKA G, POOJA, MANISH S, et al. Intermittent normobaric hypoxia facilitates high altitude acclimatization by curtailing hypoxia-induced inflammation and dyslipidemia[J]. Pflugers Arch Eur J Physiol,2019,471(7):949-959.
|
[21] |
WILSON M H, NEWMAN S, IMRAY C H. The cerebral effects of ascent to high altitudes [J]. Lancet Neurol, 2009, 8(2):175-191. DOI: 10.1016/S1474-4422(09)70014-6.
|
[22] |
YARNELL P R, HEIT J, HACKETT P H. High-altitude cerebral edema(HACE)- the Denver:front range experience [J]. Semin Neurol, 2000, 20(2):209-217. DOI: 10.1055/s-2000-9830.
|
[23] |
WEST J B, American College of Physicians, American Physiological Society. The physiologic basis of high-altitude diseases [J]. Ann Intern Med, 2004, 141(10):789-800. DOI: 10.7326/0003-4819-141-10-200411160-00010.
|
[24] |
KATJA H, NICOLE P, JORGE C, et al. Long-term exposure to intermittent hypoxia results in increased hemoglobin mass,reduced plasma volume,and elevated erythropoietin plasma levels in man[J]. Eur J Appl Physiol,2003,88(6):535-543.
|
[25] |
STEPPAN J, HOGUE C W. Cerebral and tissue oximetry [J]. Best Pract Res Clin Anaesthesiol, 2014, 28(4):429-439. DOI: 10.1016/j.bpa.2014.09.002.
|
[26] |
LAWLEY J S, LEVINE B D, WILLIAMS M A, et al. Cerebral spinal fluid dynamics:effect of hypoxia and implications for high-altitude illness[J]. J Appl Physiol, 2016, 120(2):251-262. DOI: 10.1152/japplphysiol.00370.2015.
|